SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001078782-20-000645
Filing Date
2020-08-14
Accepted
2020-08-14 15:53:07
Documents
6
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT f10q063020_10q.htm 10-Q 652111
2 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10q063020_ex31z1.htm EX-31.1 8954
3 EXHIBIT 31.2 SECTION 302 CERTIFICATION f10q063020_ex31z2.htm EX-31.2 8980
4 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10q063020_ex32z1.htm EX-32.1 3846
5 EXHIBIT 32.2 SECTION 906 CERTIFICATION f10q063020_ex32z2.htm EX-32.2 3548
6 IMAGE f10q06302010q_1.jpg GRAPHIC 35829
  Complete submission text file 0001078782-20-000645.txt   727417
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 201104778
SIC: 2834 Pharmaceutical Preparations